Case Report: Challenges of insulin and sulfonylurea dosing in an extremely premature infant for the management of KCNJ11-associated neonatal diabetes mellitus
IntroductionNeonatal diabetes mellitus (NDM) is a rare disease, the prevalence of which is 1 in 90,000–160,000 live births, with 31% of all preterm diagnoses linked to monogenic causes. NDM is differentiated into transient, permanent, and syndromic NDM. Furthermore, 40% of patients diagnosed with ND...
Saved in:
| Main Authors: | Ishan Perera, Brooke Jensen, Hirenkumar Patel, Melissa Garganta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pediatrics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1456818/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neonatal diabetes mellitus due to a new KCNJ11 mutation - 10 years of the patient`s follow-up
by: Maja D Ješić, et al.
Published: (2021-06-01) -
Feasibility of efficacious therapy of diabetes mellitus by sulfonylurea agents in neonates with KCNJII gene mutation: originalobservation
by: Andrey Olegovich Emel'yanov, et al.
Published: (2009-09-01) -
Diagnosis and Treatment of Neonatal Diabetes Caused by ATP-Channel Mutations: Genetic Insights, Sulfonylurea Therapy, and Future Directions
by: Michela Trada, et al.
Published: (2025-02-01) -
Gestasyonel diyabet gelişiminde KCNJ11 geninin rolü
by: Funda İşcioğlu, et al.
Published: (2015-12-01) -
Challenges in diagnosis and treatment of KCNJ11-MODY
by: Juliana Gonçalves, et al.
Published: (2024-12-01)